DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases.

Autor: Handelsman Y; Metabolic Institute of America, Tarzana, CA, USA. Electronic address: yhandelsman@gmail.com., Anderson JE; The Frist Clinic, Nashville, TN, USA., Bakris GL; University of Chicago Medicine, Chicago, IL, USA., Ballantyne CM; Department of Medicine, Baylor College of Medicine, Texas Heart Institute, Houston, TX, USA., Bhatt DL; Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, NY, New York, USA., Bloomgarden ZT; Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, NY, New York, USA., Bozkurt B; Department of Medicine, Baylor College of Medicine, Houston, TX, USA., Budoff MJ; David Geffen School of Medicine, UCLA, Los Angeles, CA, USA., Butler J; University of Mississippi Medical Center, Jackson, MS, USA., Cherney DZI; Division of Nephrology, Department of Medicine, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada., DeFronzo RA; University of Texas Health Science Center, San Antonio, TX, USA., Del Prato S; Interdisciplinary Research Center 'Health Science', Sant'Anna School of Advanced Studies, Pisa, Italy., Eckel RH; University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Filippatos G; Department of Cardiology, National and Kapodistrian University of Athens, Athens, Greece., Fonarow GC; David Geffen School of Medicine, UCLA, Los Angeles, CA, USA., Fonseca VA; Tulane University Health Sciences Center, New Orleans, LA, USA., Garvey WT; University of Alabama at Birmingham, Birmingham, AL, USA., Giorgino F; Department of Precision and Regenerative Medicine and Ionian Area, University of Bari Aldo Moro, Bari, Italy., Grant PJ; University of Leeds, Leeds, United Kingdom., Green JB; Division of Endocrinology, Metabolism, and Nutrition, Duke University School of Medicine, Durham, NC, USA., Greene SJ; Division of Cardiology, Duke University School of Medicine, Durham, NC, USA., Groop PH; Department of Nephrology, University of Helsinki, Finnish Institute for Health and Helsinki University HospitalWelfare, Folkhälsan Research Center, Helsinki, Finland; Department of Diabetes, Central Clinical School, Monash University, Melbourne, Australia., Grunberger G; Grunberger Diabetes Institute, Bloomfield Hills, MI, USA; Wayne State University School of Medicine, Detroit, MI, USA; Oakland University William Beaumont School of Medicine, Rochester, MI, USA; Charles University, Prague, Czech Republic., Jastreboff AM; Yale University School of Medicine, New Haven, CT, USA., Jellinger PS; The Center for Diabetes & Endocrine Care, University of Miami Miller School of Medicine, Hollywood, FL, USA., Khunti K; University of Leicester, Leicester, United Kingdom., Klein S; Washington University School of Medicine, Saint Louis, MO, USA., Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City, MO, USA., Kushner P; University of California at Irvine, Irvine, CA, USA., Leiter LA; St. Michael's Hospital, University of Toronto, Toronto, Canada., Lepor NE; David Geffen School of Medicine, UCLA, Los Angeles, CA, USA., Mantzoros CS; Harvard Medical School, Boston University School of Medicine, Boston, MA, USA., Mathieu C; Department of Endocrinology, Katholieke Universiteit Leuven, Leuven, Belgium., Mende CW; University of California San Diego School of Medicine, La Jolla, CA, USA., Michos ED; Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Morales J; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, Advanced Internal Medicine Group, PC, East Hills, NY, USA., Plutzky J; Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA., Pratley RE; AdventHealth Translational Research Institute, Orlando, FL, USA., Ray KK; Imperial College London, London, United Kingdom., Rossing P; University of Copenhagen, Copenhagen, Denmark., Sattar N; University of Glasgow, Glasgow, United Kingdom., Schwarz PEH; Department for Prevention and Care of Diabetes, Faculty of Medicine Carl Gustav Carus at the Technische Universität/TU Dresden, Dresden, Germany., Standl E; Munich Diabetes Research Group e.V. at Helmholtz Centre, Munich, Germany., Steg PG; Université Paris-Cité, Institut Universitaire de France, AP-HP, Hôpital Bichat, Cardiology, Paris, France., Tokgözoğlu L; Hacettepe University, Ankara, Turkey., Tuomilehto J; University of Helsinki, Finnish Institute for Health and Welfare, Helsinki, Finland., Umpierrez GE; Emory University, Atlanta, GA, USA., Valensi P; Polyclinique d'Aubervilliers, Aubervilliers and Paris-Nord University, Paris, France., Weir MR; Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA., Wilding J; University of Liverpool, Liverpool, United Kingdom., Wright EE Jr; Department of Medicine, Duke University Medical Center, Durham, NC, USA.
Jazyk: angličtina
Zdroj: Metabolism: clinical and experimental [Metabolism] 2024 Oct; Vol. 159, pp. 155931. Date of Electronic Publication: 2024 Jun 07.
DOI: 10.1016/j.metabol.2024.155931
Abstrakt: The spectrum of cardiorenal and metabolic diseases comprises many disorders, including obesity, type 2 diabetes (T2D), chronic kidney disease (CKD), atherosclerotic cardiovascular disease (ASCVD), heart failure (HF), dyslipidemias, hypertension, and associated comorbidities such as pulmonary diseases and metabolism dysfunction-associated steatotic liver disease and metabolism dysfunction-associated steatohepatitis (MASLD and MASH, respectively, formerly known as nonalcoholic fatty liver disease and nonalcoholic steatohepatitis [NAFLD and NASH]). Because cardiorenal and metabolic diseases share pathophysiologic pathways, two or more are often present in the same individual. Findings from recent outcome trials have demonstrated benefits of various treatments across a range of conditions, suggesting a need for practice recommendations that will guide clinicians to better manage complex conditions involving diabetes, cardiorenal, and/or metabolic (DCRM) diseases. To meet this need, we formed an international volunteer task force comprising leading cardiologists, nephrologists, endocrinologists, and primary care physicians to develop the DCRM 2.0 Practice Recommendations, an updated and expanded revision of a previously published multispecialty consensus on the comprehensive management of persons living with DCRM. The recommendations are presented as 22 separate graphics covering the essentials of management to improve general health, control cardiorenal risk factors, and manage cardiorenal and metabolic comorbidities, leading to improved patient outcomes.
Competing Interests: Declaration of competing interest None of the Task Force members received monetary renumeration for their contributions to the creation or writing of this consensus document. See the Supplementary Appendix for full declarations of competing interests for each author.
(Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: